Written By:
Sayer Ji, Founder
Believe it or not, this question has been asked for well over 60 years by researchers who stumbled upon evidence that the removal of gluten from the diet results in improved symptoms, or conversely, that gluten grain consumption leads to higher prevalence of both neurological and psychiatric problems.
Reports of the resolution of emotional disturbances after the institution of a "gluten free" diet exist in medical literature at least as far back as 1951.[i] In 1954, Sleisenger reported to have found three schizophrenics among a group of thirty-two adults with celiac disease,[ii] and in 1957, Bossak, Wang and Aldersberg reported discovering 5 psychotic patients among 94 patients with celiac disease.[iii] The initial recognition that celiac disease, or at least gluten sensitivity, occurred at a far higher prevalence among schizophrenics than the healthy, opened up the door to more elaborate investigations.
Wartime Reduction In Gluten Grain Rations Reduces Schizophrenia Prevalence
For instance, in 1966, a remarkable epidemiological study was published in The American Journal of
The author of the study, F. C. Dohan, M.D., looked at the number of women admitted to the mental hospitals in Finland, Norway, Sweden, Canada and the United States before and after World War II. These figures were then compared to volume of wheat and rye consumed during those two periods. As Dohan explains:
"The percent change in the mean annual number of first admissions for schizophrenia to the hospital in each of the five countries from the respective pre-war mean was compared to the percent change in the "consumption" of wheat and wheat plus rye."
The results can be view in the figure below:
Increasing Body of Research Implicates Gluten Grains in Schizophrenia Pathogenesis
Since then, a number of studies have been published linking the consumption of gluten-containing grains to schizophrenia:
- Schizophrenia Bulletin, 2011: Persons with schizophrenia have higher than expected titers of antibodies (7 fold increased prevalence) related to celiac disease and gluten sensitivity.[iv]
- Schizophrenia Research, 2010: Individual with schizophrenia have a novel immune response to gliadin distinct from those with celiac disease (i.e. absence of antibodies to the transglutaminase enzyme and the HLA-DQ2/DQ8 genetic locus of susceptibility.[v]
- Acta Psychiatra Scandinavica, 2006: A review of the literature found a drastic reduction, if not full remission, of schizophrenic symptoms after initiation of gluten withdrawal has been noted in a variety of studies.[vi]
- Biological Psychiatry, 1984: Only two chronic schizophrenics were found among over 65,000 examined or closely observed adults in remote regions of Papua New Guinea (PNG, 1950-1967) and Malaita , Solomon Islands (1980-1981), and on Yap , Micronesia (1947-1948), who do not consume grains. Researchers noted that when these peoples became partially westernized and consumed wheat, barley beer, and rice, the prevalence reached European levels.[vii]
- Science, 1976: Schizophrenics maintained on a grain-free and milk-free diet challenged with gluten saw interruption of their therapeutic progress. After termination of the gluten challenge, the course of improvement was reinstated.[viii]
The latest study to confirm the gluten-schizophrenia link was published this month in the World Journal of Biological Psychiatry and titled, "Elevated gliadin antibody levels in individuals with schizophrenia." Researchers compared the blood work of 950 schizophrenics with 1,000 healthy controls. They discovered that the odds ratio of having anti-gliadin IgG antibodies was 2.13 times higher in schizophrenics, indicating that t the least schizophrenics are more likely to experience an adverse immune response to wheat proteins.
Gliadin is the alcohol soluble complex of proteins found within what is known colloquially as gluten (the term is misleading as wheat technically contains over 23,000 different proteins, not one), and is considered the primary immunotoxic class of proteins in wheat. For instance, in celiac disease, a genetically mediated immune process unfurls where upon exposure to gliadin, the enzyme tissue transglutaminase modifies the protein, and the immune system cross-reacts with the small-bowel tissue, causing an inflammatory reaction that results in the destruction of the intestinal villi.
The discovery of antibodies to gliadin in the blood of both celiac disease patients and schizophrenics implies several things:
- The Wheat Protein Gliadin Doesn't Break Down During Digestion: Undigested wheat-derived macromolecules can act as antigens, provoking an antibody-mediated immune response, particularly if they get through the intestinal lining and into the blood. The fact that antibodies to wheat protein gliadin can be found in the blood indicates that it is not being fully broken down into constituent amino acids.
- Wheat Proteins In the Blood Stimulate Auto-Immunity: The presence of gliadin in the blood also indicates intestinal permeability. It turns out that gliadin has been found to up-regulate the protein zonulin in the gut of those either with or without celiac disease, which essentially opens "pandora's box" of intestinal permeability, and subsequent autoimmunity.[ix] In another essay, we also described the intestinal permeability generating effects of wheat lectin, also known as Wheat Germ Agglutinin (WGA) – [see Opening Pandora's Bread Box]
- Wheat Protein May Cause The Immune System To Attack the Nervous System: Anti-gliadin antibodies appear to cross react with neurological self-structures, which may explain how they contribute to schizophrenia. A study published in 2007 in the Journal of Immunology found that anti-gliadin antibodies bind to neuronal synapsin I, a protein found within nerve terminal of axons, which the study authors believe may explain why gliadin contributes to "neurologic complications such as neuropathy, ataxia, seizures, and neurobehavioral changes."[x] Another example of anti-gliadin antibodies possibly contributing to the formation of autoantibodies against neurological self-structures is in autism. A 2004 study in Nutritional Neuroscience found that children with autism show antibody elevations against gliadin and cerebellar (brain) proteins simultaneously. In other words, wheat proteins may simulate antibodies that cross-react, resulting in neurological damage.[xi] Learn more on the topic by reading our article: Wheat: A Missing Piece In the Autism Puzzle
Just A Problem for Schizophrenics? There Is One Surefire Way To Find Out
A broader question is also raised by this research. Since anti-gliadin antibodies are found in approximately 27% of the population, and as high as 57% in those suffering from neurological dysfunction of unknown causes,[xii] is it then possible that gluten-containing grains are adversely affecting the mental health of the world at large, perhaps mostly on a subclinical basis? We actually explored this possibility in greater depth in our essay The Dark Side of Wheat, focusing on the Roman empire's use of the wheat-based economy as a form of both cultural and biological imperialism.
Certainly we can say that wheat adversely affects the physical health of far more than present day conventional medical estimates which focus on celiac disease and food allergies to wheat. We have indexed over 200 adverse health effects of gluten-containing grains, with 20 adverse 'modes of toxicity' described thus far. Interestingly, top on the list is neurotoxicity, with 23 articles describing this effect available to view here: Wheat Neurotoxicity Link.
There are likely far too many variables to ever point to gluten-containing grains as a singular cause of psychiatric problems, malaise, mania, addiction, depression, schizophrenia, etc. However, one thing is sure. Your first hand experience is as valuable as a double-blind, placebo-controlled, randomized human trial. And so, if you remove them from your diet, and you feel better, and health conditions, both physical and mental, improve, then there is no better proof than that!
Resources[i] Haas, S. V. and Haas, M. P. Management of Celiac Disease. Philadelphia, 1951. J. B. Lippincott Co.
[ii] Sleisenger, M. H. Personal communication.
[iii] Bossak, E.T., Wang, C.I. and Adlersberg, D.I. Clinical aspects of malabsorption syndrome (idiopathic sprue). In: The Malabsorption Syndrome, New York, 1957. Grune & Stratton, Inc.
[iv] Nicola G Cascella, Debra Kryszak, Bushra Bhatti, Patricia Gregory, Deanna L Kelly, Joseph P Mc Evoy, Alessio Fasano, William W Eaton. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull. 2011 Jan;37(1):94-100. Epub 2009 Jun 3.
[v] Diana Samaroo, Faith Dickerson, Donald D Kasarda, Peter H R Green, Chiara Briani, Robert H Yolken, Armin Alaedini. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res. 2010 May;118(1-3):248-55. Epub 2009 Sep 11.
[vi] A E Kalaydjian, W Eaton, N Cascella, A Fasano. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand. 2006 Feb;113(2):82-90.
[vii] F C Dohan, E H Harper, M H Clark, R B Rodrigue, V Zigas. Is schizophrenia rare if grain is rare? Biol Psychiatry. 1984 Mar;19(3):385-99.
[viii] M M Singh, S R Kay. Wheat gluten as a pathogenic factor in schizophrenia. Science. 1976 Jan 30;191(4225):401-2.
[ix] Sandro Drago, Ramzi El Asmar, Mariarosaria Di Pierro, Maria Grazia Clemente, Amit Tripathi, Anna Sapone, Manjusha Thakar, Giuseppe Iacono, Antonio Carroccio, Cinzia D'Agate, Tarcisio Not, Lucia Zampini, Carlo Catassi, Alessio Fasano. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol. 2006 Apr;41(4):408-19.
[x] Armin Alaedini, Haruka Okamoto, Chiara Briani, Kurt Wollenberg, Holly A Shill, Khalafalla O Bushara, Howard W Sander, Peter H R Green, Mark Hallett, Norman Latov. Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J Immunol. 2007 May 15 ;178(10):6590-5.
[xi] A Vojdani, T O'Bryan, J A Green, J Mccandless, K N Woeller, E Vojdani, A A Nourian, E L Cooper. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci. 2004 Jun;7(3):151-61.
[xii] M Hadjivassiliou, A Gibson, G A Davies-Jones, A J Lobo, T J Stephenson, A Milford-Ward . Does cryptic gluten sensitivity play a part in neurological illness? Lancet. 1996 Feb 10;347(8998):369-71.
No hay comentarios:
Publicar un comentario